Can the nice "end-of-life premium" be given a coherent ethical justification?

Journal of Health Politics, Policy and Law

Volumn 38, Issue 6, 2013, Pages 1129-1148

  Cookson, Richard ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECONOMICS; ETHICS; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; LIFE EXPECTANCY; NATIONAL HEALTH SERVICE; POLITICS; QUALITY ADJUSTED LIFE YEAR; TIME; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; GREAT BRITAIN; HEALTH CARE RATIONING; HEALTH POLICY; HUMANS; LIFE EXPECTANCY; POLITICS; QUALITY-ADJUSTED LIFE YEARS; STATE MEDICINE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TIME FACTORS;

EID: 84890848005     PISSN: 03616878     EISSN: 15271927     Source Type: Journal    
DOI: 10.1215/03616878-2373166     Document Type: Article

References (22)

1. Becker, B., K. Murphy, and T. Philipson. 2007. The Value of Life near Its End and Terminal Care. Cambridge, MA: National Bureau of Economic Research.
2. Brock, D. 1988. "Ethical Issues in Recipient Selection for Organ Transplantation." In Organ Substitution Technology: Ethical, Legal, and Public Policy Issues, edited by D. Mathieu, 86-99. Boulder, CO: Westview.
3. Brock, D. W. 2010. "Ethical and Value Issues in Insurance Coverage for Cancer Treatment." Oncologist 15 (suppl. 1): 36-42. doi:10.1634/theoncologist.2010-S1-36.
4. Broome, J. 1988. "Good, Fairness, and Qalys." In Philosophy and Medical Welfare, edited by M. Bell and S. Mendus, 57-74. Cambridge: Cambridge University Press.
5. Chilton, S., et al. 2006. "Dread Risks." Journal of Risk and Uncertainty 33, no. 3: 165-82. doi:10.1007/s11166-006-0483-z.
6. Claxton, K., et al. 2013. "Methods for the Estimation of the NICE Cost Effectiveness Threshold." CHE Research Paper 81, University of York Centre for Health Economics, January.
7. Cookson, R., C. McCabe, and A. Tsuchiya. 2008. "Public Healthcare Resource Allocation and the Rule of Rescue." Journal of Medical Ethics 34, no. 7: 540-44. doi:10.1136/jme.2007.021790.
8. Daniels, N. 2000. "Accountability for Reasonableness." British Medical Journal 321, no. 7272: 1300-1301. doi:10.1136/bmj.321.7272.1300.
9. Daniels, N., and J. E. Sabin. 2008. "Accountability for Reasonableness: An Update." British Medical Journal 337: a1850. doi:10.1136/bmj.a1850.
10. Jenni, K. E., and G. Lowenstein. 1997. "Explaining the 'Identifiable Victim Effect."' Journal of Risk and Uncertainty 14, no. 3: 235-57. doi:10.1023/A :1007740225484.
11. Jonsen, A. R. 1986. "Bentham in a Box: Technology Assessment and Health Care Allocation." Law, Medicine and Health Care 14: 172-74.
12. Longson, C., and P. Littlejohns. 2009. Update Report on the Application of the "End-of-Life" Supplementary Advice in Health Technology Appraisals. London: National Institute for Health and Clinical Excellence.
13. Menzel, P. T. 2011. "The Value of Life at the End of Life: A Critical Assessment of Hope and Other Factors." Journal of Law, Medicine and Ethics 39, no. 2: 215-23. doi:10.1111/j.1748-720X.2011.00590.x.
14. NICE (National Institute for Health and Clinical Excellence). 2002. Guidance on the Use of Trastuzumab for the Treatment of Advanced Breast Cancer. London: National Institute for Health and Clinical Excellence.
15. NICE (National Institute for Health and Clinical Excellence). 2003. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence.
16. NICE (National Institute for Health and Clinical Excellence). 2008. Social Value Judgements: Principles for the Development of NICE Guidance. 2nd ed. London: National Institute for Health and Clinical Excellence.
17. NICE (National Institute for Health and Clinical Excellence). 2009. Appraising Life- Extending, End of Life Treatments. London: National Institute for Health and Clinical Excellence.
18. Nord, E. 1993. "The Trade-offbetween Severity of Illness and Treatment Effect in Cost-Value Analysis of Health Care." Health Policy (Amsterdam) 24, no. 3: 227-38. doi:10.1016/0168-8510(93)90042-N.
19. Shah, K., et al. 2011. "NICE's Social Value Judgements about Equity in Health and Health Care." University of York: Centre for Health Economics CHE Research Paper 70.
20. Smith, P. 2012. "Incorporating Financial Protection into Decision Rules for Publicly Financed Healthcare Treatments." Health Economics 22, no. 2: 180-93. doi: 10.1002/hec.2774.
21. Stolk, E. A., et al. 2004. "Reconciliation of Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using Proportional Shortfall." PharmacoEconomics 22, no. 17: 1097-107. doi:10.2165/00019053-200422170-00001.
22. Sunstein, Cass R. 1997. "Bad Deaths." Journal of Risk and Uncertainty 14, no. 3: 259-82. doi:10.1023/A:1007792209554.